Skip to main content
Watch Insiders

Corporate insider profile

Michael Thomas Henderson Insider Trades

Latest reported as Chief Executive Officer of Apogee Therapeutics, Inc. (APGE).

Purchase filings
0
Reported companies
2
Net open-market value
-$24,537,180.00
Latest transaction
Jul 8, 2026

Affiliated corporations

Reported company relationships

APGELatest reported

Apogee Therapeutics, Inc.

Chief Executive Officer

SYREPrior filing

Spyre Therapeutics, Inc.

Corporate insider

Transaction history

Open-market Transactions

Open-market insider purchase and sale transactions
DateCompanyRoleTypeSharesPriceTotal value
Jul 8, 2026Apogee Therapeutics, Inc. (APGE)Chief Executive OfficerSale20,000$133.63$2,672,600
Jun 22, 2026Spyre Therapeutics, Inc. (SYRE)Corporate insiderSale20,000$100.00$2,000,000
Jun 22, 2026Apogee Therapeutics, Inc. (APGE)Chief Executive OfficerSale80,000$132.54$10,603,200
Jun 10, 2026Apogee Therapeutics, Inc. (APGE)Chief Executive OfficerSale20,000$83.38$1,667,622
May 13, 2026Apogee Therapeutics, Inc. (APGE)Chief Executive OfficerSale20,000$82.09$1,641,710
May 8, 2026Spyre Therapeutics, Inc. (SYRE)Corporate insiderSale80,000$74.40$5,952,048